A reviewer's-eye read on which documentation elements carry a recertification and which ones get skipped.
Adam Gupilan, LVN — Utilization Management
A recertification is not read as a clinical narrative. It is read as a search for specific findings that satisfy specific criteria. The reviewer is not asking is this patient sick. They are asking can I locate, in this record, evidence of decline across these two periods.
Everything below is organized by that distinction: what a reviewer can act on versus what they read past.
Skipped: A single weight. "168 lbs."
Carries: Weight with the fluid state that explains it, plus the direction of both.
"168 lbs, up 1 lb from 8/14. Edema progressed 1+ ankles → 2+ mid-calf over the same interval. Torsemide increased 20 → 40 mg on 8/20."
Why it matters: in end-stage CHF, weight is confounded by volume. A stable or rising weight is the expected finding in a declining patient, which means an uncontextualized weight actively argues against eligibility. The discordance is the evidence.
The strongest single line most notes omit: a rising diuretic requirement holding weight flat. That is decline expressed numerically, and almost nobody writes it.
Skipped: "Patient is weak." "Requires assistance with ADLs." "Bed-bound."
Carries: The same finding with a prior state and an interval.
"Ambulated 20 ft with walker at admission; now transfers bed-to-chair only, two-person assist, as of 8/22."
Why it matters: descriptive statements establish severity, not trajectory. Severity does not support recertification — a patient can be severely impaired and stable for years. Only the delta supports it.
PPS caution: a PPS scored generously at admission creates a baseline the patient must fall from. If admission PPS was inflated, later periods read as stable regardless of what actually happened. From the review side this is invisible — I see a flat line, not an inflated starting point.
Skipped: "Poor appetite." "Eating less."
Carries: Quantified intake, a trend, and the consequence.
"Intake 40% of meals, down from 75% in June. MAC 24.5 cm → 23.1 cm. Supplements initiated 7/8; intake unchanged at 4 weeks."
Why it matters: reduced intake is exposure. Lean-mass loss and failure to respond to intervention are impact. Decline that continued despite intervention is one of the strongest eligibility statements available and is rarely written.
Note on labs: albumin and prealbumin are charted as malnutrition evidence constantly. Both are negative acute-phase reactants and are confounded by inflammation. Reviewers largely discount them. Serial anthropometrics — mid-arm circumference, or any measure at a site fluid doesn't reach — carry considerably more weight and cost nothing.
Skipped: "Dyspnea." "SOB with exertion."
Carries:
"Dyspnea at rest 4 of 7 days this week vs. 1 of 7 in July. Sleeps on 3 pillows, up from 2. Two PRN morphine doses/day, up from 0.5."
Why it matters: presence of a symptom is a diagnosis feature. Frequency and escalation are trajectory. PRN medication trends are among the cleanest decline signals in the chart because they are timestamped, quantitative, and already captured — they simply never make it into the narrative.
Skipped: Nothing documented, because "no hospitalization" feels like the absence of information.
Carries: Explicitly stated events or explicitly stated avoidance.
"Two episodes of acute decompensation managed at home 7/29 and 8/16, both requiring IV diuresis and additional RN visits; hospitalization avoided per goals of care."
Why it matters: avoided admissions are invisible to a reviewer unless charted, and they are strong evidence of both decline and the hospice benefit working. Silence reads as stability.
If a recert note contains these five comparisons with intervals, it will clear review in most cases regardless of diagnosis:
Everything else in the note serves care. These five serve the claim.
Most notes document a finding. Reviews are decided by the comparison.
"Edema 2+" is a data point. "Edema 2+, up from 1+ at the ankle three weeks ago" is an argument.
Written from the utilization management side. No product attached to this — if any of it is useful for the documentation series, take it.
This series is written one diagnosis at a time, and the useful ones to write next are the ones people are actually losing. If there's a recertification or authorization that keeps coming back on your charts and it isn't covered above, name it and I'll write it up.
No cost, no pitch attached, and nothing patient-specific — the diagnosis and the setting is all I need. If it's a common one, it goes into the series so everyone gets it.
Name a diagnosis →I do utilization review on the payer side, so this is written from the chair the note actually lands in. I also build software for this, at getclinicalflow.com — but nothing above depends on it and there's no obligation attached to asking.
Adam Gupilan, LVN — utilization management. I review the prior authorizations and recertifications that providers submit, which is where everything above comes from.
Nothing here is attached to a product. If it's useful in your charts, use it. More at the full series, or getclinicalflow.com.
Written from the reviewer's side and offered as general documentation guidance. It is not clinical, legal, or billing advice, and it does not reproduce any proprietary criteria text. Eligibility determinations are made by the certifying physician and the reviewing plan.